Related Experiment Video
Updated: May 29, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Endothelial dysfunction in uremic patients on continuous ambulatory peritoneal dialysis (CAPD)
Senija Rašić1, Almira Hadžović-Džuvo, Damir Rebić
1Clinic of Nephrology, University of Sarajevo Clinical Center, Bosnia and Herzegovina. rasicnef@bih.net.ba
Diabetic patients on continuous ambulatory peritoneal dialysis (CAPD) show significant endothelial dysfunction and increased cardiovascular risk compared to non-diabetic CAPD patients. Biomarkers indicate systemic alterations contributing to this higher risk.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Endothelial dysfunction is linked to diabetic complications and declining kidney function.
- Patients undergoing continuous ambulatory peritoneal dialysis (CAPD) may experience endothelial dysfunction.
Purpose of the Study:
- To investigate plasma biomarkers of endothelial dysfunction in CAPD patients.
- To assess the association between these biomarkers and carotid artery intima-media thickness (IMT) in diabetic versus non-diabetic CAPD patients.
Main Methods:
- Study included 37 CAPD patients (25 with type 2 diabetes, 12 non-diabetic).
- Measured plasma biomarkers: von Willebrand factor (vWF) activity, albumin, glucose, lipids (cholesterol, triglycerides, Lp(a)), homocysteine, parathyroid hormone (PTH).
- Assessed carotid intima-media thickness (IMT) using ultrasound.
Main Results:
- Mean IMT was significantly higher in diabetic CAPD patients (0.86 mm) vs. non-diabetic (0.52 mm) (p<0.0001).
- Diabetic patients exhibited significant differences in lipid profiles, procoagulation factors (vWF, Factor VIII), and inflammatory markers (CRP).
- Log triglycerides and Factor VIII were independent predictors of IMT.
Conclusions:
- Diabetic type 2 CAPD patients exhibit systemic endothelial dysfunction.
- These patients face a higher risk of cardiovascular complications compared to non-diabetic CAPD patients.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Continuous Renal Replacement Therapy
Peritoneal Dialysis III: Nursing Management
Hemodialysis I: Introduction
Peritoneal Dialysis I: Introduction and Procedure
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

